Testicular seminoma (pure) stage II – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:37:01 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Testicular seminoma (pure) stage II – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Reduced Intensity Radio-Chemotherapy for Stage IIA/B Seminoma Using Etoposide, Cisplatin, and Carboplatin for Patients with Stage IIA/B Seminoma https://clinicaltrials.eu/trial/study-on-reduced-intensity-radio-chemotherapy-for-stage-iia-b-seminoma-using-etoposide-cisplatin-and-carboplatin-for-patients-with-stage-iia-b-seminoma/ Wed, 29 Apr 2026 15:00:48 +0000 https://clinicaltrials.eu/trial/study-on-reduced-intensity-radio-chemotherapy-for-stage-iia-b-seminoma-using-etoposide-cisplatin-and-carboplatin-for-patients-with-stage-iia-b-seminoma/ This clinical trial is focused on studying a type of cancer called Stage IIA/B seminoma, which is a form of testicular cancer. The study is exploring a treatment approach that combines reduced intensity radio-chemotherapy. The medications being used in this study include Etomedac (active substance: etoposide), Cisplatin NeoCorp (active substance: cisplatin), and Carboplat onkovis (active substance: carboplatin). These medications are administered as a solution for infusion, which means they are given through a vein.

The purpose of the study is to investigate the effectiveness of this treatment regimen for patients with Stage IIA/B seminoma. Participants in the study will receive the treatment over a period of time, and their health will be monitored to see how well the cancer responds to the treatment. The study will also look at how long patients remain free from cancer progression, which means the cancer does not get worse, over a period of three years.

Throughout the study, various health assessments will be conducted, including imaging tests like CT or MRI scans, to check the status of the cancer. The study aims to gather information on the response rate to the treatment, the time it takes for the cancer to progress, and overall survival rates. This information will help in understanding the potential benefits of the treatment for patients with this type of cancer.

]]>